
About Vidman Pharmaceuticals Private Limited
Data last updated:
Vidman Pharmaceuticals Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 07 August 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24110GJ2017PTC098605. Its GSTIN is 24AAGCK7135H1ZK (Gujarat).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Mohammadriyaz Abdulsattar Panara and Aashay Jayantilal Patel.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Block – A Shop – 114 Ganesh Meridian Opp. High Court S.G. Highway Ghatlodia, Ahmedabad, Gujarat, India – 380061.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.52 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.28 Lakh (net margin 0.4%) and EBITDA of ₹83.17 Lakh (EBITDA margin 23.7%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 6% over five years.
The company has about 15 employees on its provident fund (EPFO) records.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website krigenpharma.com.
Company details
Contact details
Vidman Pharmaceuticals Private Limited's registered office is in Ahmedabad, Gujarat. Its website is krigenpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressBlock – A Shop – 114 Ganesh Meridian Opp. High Court S.G. Highway Ghatlodia, Ahmedabad, Gujarat, India – 380061
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Vidman Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Vidman Pharmaceuticals is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Vidman Pharmaceuticals Private Limited, buy the company report.
Financials of Vidman Pharmaceuticals Private Limited
FY 2025 filings availableVidman Pharmaceuticals Private Limited reported revenue of ₹3.52 Cr (up 231% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 231% growth in the latest year. EBITDA rose 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹83.17 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.28 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 23.7% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vidman Pharmaceuticals Private Limited, buy the company report.
Board of directors of Vidman Pharmaceuticals Private Limited
Vidman Pharmaceuticals has 4 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohammadriyaz Abdulsattar Panara | Director | 21 Jan 2020 | 6 Years 9 Months | Current |
| Aashay Jayantilal Patel Also directs: Brichem Sciences Private Limited, Someshwar Ispat Private Limited, Maharshi Pharma Chem Private Limited and 1 more | Director | 05 Aug 2019 | 7 Years 3 Months | Current |
| Mittalkumar Jagdishbhai Patel Also directs: Brichem Sciences Private Limited, Someshwar Ispat Private Limited | Director | 05 Aug 2019 | 7 Years 3 Months | Current |
| Bhavesh Vikrambhai Bhavsar Also directs: Vetsi Pharma LLP | Director | 18 Nov 2017 | 8 Years 11 Months | Current |
Auditor
Vidman Pharmaceuticals Private Limited is audited by KEYUR KARWA & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KEYUR KARWA & CO. | FY 2023 | 148927W |
Shareholding
The shareholding of Vidman Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Vidman Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Vidman Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vidman Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Vidman Pharmaceuticals Private Limited has a workforce of 15 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
GST
Vidman Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAGCK7135H1ZK | Gujarat | Active | 17 Oct 2017 |
To see the full GST registrations and return filing status of Vidman Pharmaceuticals Private Limited, buy the company report.
Recent activity
Vidman Pharmaceuticals Private Limited has 11 board changes on record since 2017: 4 appointments and 7 cessations. The latest: Rajeshkumar Becharbhai Gami ceased to be Director on 01 Mar 2025.
2 earlier events are in the company report.
Frequently asked questions
Vidman Pharmaceuticals is an active private limited company based in Ahmedabad, Gujarat, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 07 August 2017 (9+ years old) and is registered under CIN U24110GJ2017PTC098605.
Vidman Pharmaceuticals has 4 current directors:
- Mohammadriyaz Abdulsattar Panara - Director
- Aashay Jayantilal Patel - Director
- Mittalkumar Jagdishbhai Patel - Director
- Bhavesh Vikrambhai Bhavsar - Director
The latest financial statements of Vidman Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Vidman Pharmaceuticals is 24AAGCK7135H1ZK, registered in Gujarat.
The CIN (Corporate Identification Number) of Vidman Pharmaceuticals is U24110GJ2017PTC098605. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vidman Pharmaceuticals was incorporated on 07 August 2017, making it 9+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Rajeshkumar Becharbhai Gami ceased to be Director on 01 Mar 2025. Mohammadriyaz Abdulsattar Panara ceased to be Additional Director on 31 Oct 2020. Mohammadriyaz Abdulsattar Panara was appointed as Director on 21 Jan 2020. Vidman Pharmaceuticals has 11 board changes on record in total.
Vidman Pharmaceuticals can be reached through the website krigenpharma.com. Its registered office is in Ahmedabad, Gujarat, India.
The registered office of Vidman Pharmaceuticals is at Block – A Shop – 114 Ganesh Meridian Opp. High Court S.G. Highway Ghatlodia, Ahmedabad, Gujarat, India – 380061.
Vidman Pharmaceuticals operates in the pharma industry, in the pharma contract r and d segment.

